The Israeli Translational Research Network

CRIR  Selected Lectures

The Annual Meeting of the Israeli Translational Research Network

The Annual Meeting of the Israeli Translational Research Network

Tuesday, March 14 2023 – View the Program

Rambam Health Care Campus

Click HERE for Free Registration!


The Israeli Translational Research Network Webinars


A groundbreaking consortium of multidisciplinary collaborations between researchers and healthcare providers to promote Bench-to-Bedside Research. As part of its scientific activity, the Clinical Research Institute at Rambam (CRIR) established in 2018 the Annual Meeting of the Israeli Translational Research (ITR).
Due to the COVID-19 outbreak, the Annual Conference of The Israeli Translational Research cannot 'take place as planned. In the interest of the ITR community, it was decided to initiate a series of bi-monthly Webinar sessions with peer speakers, in order to maintain contact and update each other with the latest medical and scientific developments.
We are highly committed to our mission to further strengthen the multidisciplinary translational research community in Israel, by encouraging research collaborations that may yield major insights forming the basis for breakthrough discoveries leading to lifesaving therapies.

We are happy to announce that the Israeli Translational Research (ITR) network, founded by the Clinical Research Institute at Rambam (CRIR), is now organized in collaboration with the Israel Innovation Authority. We deeply appreciate and are most grateful for this important recognition, and are looking forward to a fruitful and successful activity.

 Taking the kidney to a new dimension: 3D cellular models for regenerative medicine, disease modelling and drug discovery

Lecturer: Prof. Benjamin Dekel, MD, PhD; Director, Division of Pediatric Nephrology; Director, Pediatric Stem Cell Research Institute; Edmond & Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Pearl and Dr. (MD) Yechezkiel Klayman Chair in Nephro-Urology; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

February 22; 2022



Tissue Organoids Models of Human Development, Disease and Therapy Development

Lecturer: Shay Soker PhD. Professor of Regenerative Medicine, Cancer Biology and Biomedical Engineering Chief Science Program Officer, Wake Forest Institute for Regenerative Medicine Wake Forest School of Medicine, Winston-Salem, NC, USA
December 15, 2021
Innovative Biological Solutions for the Study and Treatment of Cardiovascular Disorders
Lecturer: Prof. Lior Gepstein, MD PhD Director, Department of Cardiology, Director, Division of Research, Member Clinical Research Institute at Rambam (CRIR), Rambam Health Care CampusHead, Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, The Rappaport Faculty of Medicine, Technion - Israel Institute of Technology.



P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression

Lecturer: Prof. Ronit Satchi-Fainaro, Ph.D.Head, Cancer Research and Nanomedicine Laboratory Kurt and Herman Lion Chair in Nanosciences and NanotechnologiesDirector, Cancer Biology Research Center, Tel Aviv University.


Bridging the Data-Insight Gap – Computational Disease Models for Drug Development

Lecturer, Shai Shen-Orr, PhD
April 22, 2021


Nano vaccines delivery via a “band-aid like” microneedle patch - Applications in COVID-19 and other infectious diseases

February 10, 2021
Lecturer: Professor Martin D’Souza, Ph.D Executive Editor, Journal of Translational Medicine Endowed Chair of Pharmaceutics Co-Director,
Center for Drug Delivery Nanotechnology Laboratory College of Pharmacy, Mercer University, Atlanta, USA


Reversing Personalized Medicine

 October 12, 2020
Lecturer:  Professor Gal Markel, MD PhD MBA
Director, Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center



Host-response based Dx in antibiotics misuse, SARS-Cov-2 and beyond

October 10, 2020
Lecturer:    Dr. Kfir Oved,  PhD
Co-founder, CTO, Chairman MeMed DX
Founder, CEO, Canopy Immuno-Therapeutics